Intravenous Immunoglobulins in the Third Millennium | Marinos C. Dalak

Book

Intravenous Immunoglobulins in the Third Millennium

ABSTRACT

Intravenous Immunoglobulins In the Third Millennium is a highly authoritative review of the pharmacology and therapeutic use of these agents. Based on the famous Interlaken IVIG International Symposium held every five years, and written by an internationally recognized team of expert scientists and clinicians, the book reviews the major challenges

TABLE OF CONTENTS

part 2|1 pages

Decacdes of Experience with Intravenous Immunoglobulin

chapter 1|5 pages

Treatment modalities and clinical efficacy of immunoglobulin G replacement therapies in primary immunodeficiency

chapter 2|12 pages

Challenges and Achievements in Pathogen Safety of Intravenous Immunoglobulin

chapter 3|8 pages

Treatments Modalities and Clinical Eficacy of Replacement Therapies in Primary Immunodeficiency

chapter 4|7 pages

Immunomodulation by Intravenous Immunoglobulin: Idiopathic Thrombocytopenic Purpura as a Model

chapter 5|3 pages

Witnessing the Introduction and Use of Intravenous Immunoglobulin in Neurology

chapter 6|5 pages

Pharmacoeconomics of Intravenous Immunoglobulin Administration in Neurological Disorders: The US Experience

chapter 7|5 pages

Pharmacoeconomics of Intravenous Immunoglobulin for Polyneuropathies

part |1 pages

Intravenous Immunoglobulin in Immunodeficiencies and Severe Infection—Molecular Aspects and Clinical Use

chapter 8|5 pages

B-cell Maturation to Produce High-affinity Antibodies of Different Isotopes and its Abnormalities

chapter 9|13 pages

The Molecular Basis of Primary Immune Deficiency Diseases

chapter 10|6 pages

Safety in Intravenous Immunoglobulin Therapy

chapter 11|4 pages

Immunoglobulin Replacement by the Subcutaneous Route Using Preparations Licensed in for Administration by Other Routes

chapter 12|4 pages

The Use of Intranenous Immunoglobulin for Allogeneic Stem Cell Transplantations: The US Experience

chapter 13|6 pages

Intravenous Immunoglobulin for Bone Marrow Stem Cell Transplantation the European Experience

chapter 14|3 pages

Secondary Antibody Deficiency Following Ttreatment of Vasculitis: The Use of Intravenous Immunoglobulin

chapter 15|8 pages

Intravenous Immunoglobulin In the Prevention and Treatment of Severe Infections

part |1 pages

Immunomodulatory and Anti-inflammatory Potential of Intravenous Immunoglobulin

chapter 16|6 pages

Mechanisms of Intravenous Immunoglobulin in Autoimmune and Inflammatory Diseases

chapter 17|7 pages

Role of Intravenous Immunoglobulin in Reversing Glucocorticoid Insensitivity or Resistance

chapter 18|5 pages

Modulating the Balance of Activating and Inhibiting Fcγ Receptors: Mechanism of Intravenous Immunoglobulin Action

chapter 19|5 pages

Anti-inflammatory Effects of Intravenous Immunoglobulin: Fcγ receptor inhibition/blockade and non-Fcγ Receptor-mediated Mechanism

chapter 20|4 pages

Immune Modulation by Intravenous Immunoglobulin: Some Remarks on the Role of Fc Receptors

chapter 21|6 pages

Intravenous Immunoglobulin in Reactive Hemophagocytic Syndrome: A of Fcγ Receptor and Cytokine Modulation

chapter 22|6 pages

Anti-inflammatory Effects of Intravenous Immunoglobulin Through Modulation of Complement Activities

chapter 23|5 pages

Changes in Gene Expression Profile in the Muscles of Patients with Dermatomyositis and Inclusion Body Mysoitis After Therapy with Intravenous Immunoglobulin: A Microarray Analysis Correlating Gene Expression with Clinical Outcomes

chapter 24|7 pages

In Vitro Studies of Mechanisms of Action of Intravenous Immunoglobulin in Guillain-Barree Syndrome and Miller-Fisher Syndrome: A Review

part |3 pages

Intravenous Immunoglobulin for Autoimmune Dieseases of the Peripheral Nervous System

chapter 25|9 pages

The Immunological Rationale for Intravenous Immunoglobulin in Guillian-Barre Syndrome and Chronic Inflammatory Demylinating Polyradiculoneuropathy

chapter 26|10 pages

Intravenous Immunoglobulin for Guillain-Barre Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Adult Patients

chapter 27|5 pages

Clinical Experience with Intravenous Immunoglobulin for Treatment of Pediatric Guillain-Barre Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy

chapter 28|3 pages

Intravenous Immunoglobulin for Multifocal Motor Neuropathy

chapter 29|6 pages

Intravenous Immunoglobulin in ParaProteinemic Demyelinating Neuropathies

chapter 30|5 pages

Immunoglobulins in IgM Antimyelin-Associated Glycoprotein and Other Paraprotein and Other Paraproteinemic Neuropathies

chapter 31|3 pages

Intravenous Immunoglobulin for Myasthenia Gravis

chapter 32|5 pages

Intravenous Immunoglobulin in Polymyositis and Dermatomyositis

chapter 33|6 pages

Controlled Studies with High-Dose Intravenous Immunoglobulin in the Treatment of Inclusion Body Myositis

part |2 pages

Intravenous Immunoglobulin for Autoimmune Diseases of the Central Nervous System

chapter 34|7 pages

Immune Mechanism and Treatment Perspectives in Multiple Sclerosis

chapter 35|6 pages

A Review of Intravenous Immunoglobulin in Multiple Sclerosis

chapter 36|7 pages

Intravenous Immunoglobulin Treatment for Patients with Primary or Secondary Progressive Multiple Sclerosis

chapter 37|13 pages

What is the Effect of Intravenous Immunoglobulin for Treatment of Ralapsing-Remitting Multiple Sclerosis?

chapter 38|11 pages

High-dose Intravenous Immunoglobulin In the Treatment of Patients with Stiff Person Syndrome: A Controlled Study

chapter 39|9 pages

Intravenous Immunoglobulin in Acute Disseminated Encephalomyelitis

part |2 pages

The Use of Intravenous Immunoglobulin in Dermatology

chapter 40|4 pages

Intravenous Immunoglobulin in Dermatology

chapter 41|8 pages

The Use of Intravenous Immunoglobulin Therapy in of Autoimmune Mucocutaneous Blistering Diseases

chapter 42|6 pages

Treatment of Atopic Dermatitis, Urticaria and Psoriasis with Intravenous Immunoglobulin

chapter 43|4 pages

Intravenous Immunoglobulin in Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome

chapter 44|11 pages

Intravenous Immunoglobulin in the Treatment of Vasculitis

part |2 pages

Emerging Applications for Intravenous Immunoglobulin

chapter 45|7 pages

Immunomodulation by Intravenous Immunoglobulin of Alloantibodies to Human Leukocyte Antigen: Clinical Aspect in Solid Organ Transplantation

chapter 46|10 pages

Role of intravenous immunoglobulin in the management of heart failure

chapter 47|6 pages

Intravenous Immunoglobulin: Potential Role in the Management of Severe Acute Respiratory Syndrome

chapter 48|4 pages

Enchancement of the Immune Response to Mycobacterium Tuberculosis by High-dose Intravenous Immunoglobulin in Mice

part |2 pages

Potential Applications for Intravenous Immunoglobulin

chapter 49|5 pages

Intravenous Immunoglobulin for Treatment of Recurrent Miscarriage

chapter 50|8 pages

Epilepsy and the immune system: is there a link?

chapter 51|4 pages

Intravenous Immunoglobulin as an Immunomodulatory Agent in Systemic Lupus Eruthematosus and Lupus Nephritis

chapter 52|6 pages

Intravenous Immunoglobulin for Fibrosis, Atherosclerosis and Malignant Conditions

part |2 pages

Summaries of poster sessions

chapter 53|4 pages

Intravenous Immunoglobulin for Immune Deficiencies and Passive Immunization

chapter 54|5 pages

The Use of Intravenous Immunoglobulin in Hematology and Transplantation

chapter 55|6 pages

The of Intravenous Immunoglobulin in Neurology

chapter 56|5 pages

The Use of Intravenous Immunoglobulin for Dermatological Disorders

chapter 57|3 pages

The Use of Intravenous Immunoglobulin in Collagen Vascular and Heart Diseases

chapter 58|4 pages

Intravenous Immunoglobulin: Machanisms of Action

chapter 59|7 pages

Pathogen Safety and Tolerability of Intravenous Immunoglobulin

chapter 60|5 pages

Pharmacoeconomics and Evidence-based Medicine G.Antonini and A.Di Pasquale